Collecting antibodies and large molecule biomarkers in mouse interstitial brain fluid: a comparison of microdialysis and cerebral open flow microperfusion

References

• Southwell AL, Patterson PH. Antibody therapy in neurodegenerative disease. Rev Neurosci. 2010;21:273–14.
   PubMed Web of Science ®Google Scholar
• Schlegel K, Awwad K, Heym RG, Holzinger D, Doell A, Barghorn S, Jahn TR, Klein C, Mordashova Y, Schulz M, et al. N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain. Acta Neuropathol Commun. 2019;7(1):177. doi:10.1186/s40478-019-0831-2.
   PubMed Web of Science ®Google Scholar
• Dong X. Current strategies for brain drug delivery. Theranostics. 2018;8(6):1481–93. doi:10.7150/thno.21254.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Delivery of biologics across the blood-brain barrier with molecular trojan horse technology. BioDrugs. 2017;31(6):503–19. doi:10.1007/s40259-017-0248-z.
   PubMed Web of Science ®Google Scholar
• Cao Y, Balthasar JP, Jusko WJ. Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies. J Pharmacokinet Pharmacodyn. 2013;40(5):597–607. doi:10.1007/s10928-013-9332-2.
   PubMed Web of Science ®Google Scholar
• Eigenmann MJ, Karlsen TV, Krippendorff BF, Tenstad O, Fronton L, Otteneder MB, Wiig H. Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches. J Physiol. 2017;595(24):7311–30. doi:10.1113/JP274819.
   PubMed Web of Science ®Google Scholar
• Lada MW, Kennedy RT. Quantitative in vivo monitoring of primary amines in rat caudate nucleus using microdialysis coupled by a flow-gated interface to capillary electrophoresis with laser-induced fluorescence detection. Anal Chem. 1996;68(17):2790–97. doi:10.1021/ac960178x.
   PubMed Web of Science ®Google Scholar
• Parrot S, Bert L, Mouly-Badina L, Sauvinet V, Colussi-Mas J, Lambás-Señas L, Robert F, Bouilloux JP, Suaud-Chagny MF, Denoroy L, et al. Microdialysis monitoring of catecholamines and excitatory amino acids in the rat and mouse brain: recent developments based on capillary electrophoresis with laser-induced fluorescence detection–a mini-review. Cell Mol Neurobiol. 2003;23(4–5):793–804. doi:10.1023/A:1025009221285.
   PubMed Web of Science ®Google Scholar
• Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Curr Protoc Neurosci. 2009; Chapter 7, Unit7:1.
   PubMedGoogle Scholar
• Winter CD, Iannotti F, Pringle AK, Trikkas C, Clough GF, Church MK. A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. J Neurosci Methods. 2002;119(1):45–50. doi:10.1016/S0165-0270(02)00153-X.
   PubMed Web of Science ®Google Scholar
• Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma. 2005;22(1):3–41. doi:10.1089/neu.2005.22.3.
   PubMed Web of Science ®Google Scholar
• Clough GF. Microdialysis of large molecules. AAPS J. 2005;7(3):E686–92. doi:10.1208/aapsj070369.
   PubMed Web of Science ®Google Scholar
• Jadhav SB, Khaowroongrueng V, Derendorf H. Microdialysis of Large Molecules. J Pharm Sci. 2016;105(11):3233–42. doi:10.1016/j.xphs.2016.08.016.
   PubMed Web of Science ®Google Scholar
• Chang HY, Morrow K, Bonacquisti E, Zhang W, Shah DK. Antibody pharmacokinetics in rat brain determined using microdialysis. MAbs. 2018;10(6):843–53. doi:10.1080/19420862.2018.1473910.
   PubMed Web of Science ®Google Scholar
• Takeda S, Sato N, Ikimura K, Nishino H, Rakugi H, Morishita R. Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse. Neuroscience. 2011;186:110–19. doi:10.1016/j.neuroscience.2011.04.035.
   PubMed Web of Science ®Google Scholar
• Jacobson I, Sandberg M, Hamberger A. Mass transfer in brain dialysis devices–a new method for the estimation of extracellular amino acids concentration. J Neurosci Methods. 1985;15(3):263–68. doi:10.1016/0165-0270(85)90107-4.
   PubMed Web of Science ®Google Scholar
• Shippenberg TS, Thompson AC. Overview of microdialysis. Curr Protoc Neurosci. 2001; Chapter 7, Unit7:1.
   PubMedGoogle Scholar
• Boespflug EL, Iliff JJ. The emerging relationship between interstitial fluid-cerebrospinal fluid exchange, amyloid-β, and sleep. Biol Psychiatry. 2018;83(4):328–36. doi:10.1016/j.biopsych.2017.11.031.
   PubMed Web of Science ®Google Scholar
• Li X, Jusko WJ, Cao Y. Role of interstitial fluid turnover on target suppression by therapeutic biologics using a minimal physiologically based pharmacokinetic Model. J Pharmacol Exp Ther. 2018;367(1):1–8. doi:10.1124/jpet.118.250134.
   PubMed Web of Science ®Google Scholar
• Trickler WJ, Miller DW. Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. J Pharm Sci. 2003;92(7):1419–27. doi:10.1002/jps.10410.
   PubMed Web of Science ®Google Scholar
• Altendorfer-Kroath T, Schimek D, Eberl A, Rauter G, Ratzer M, Raml R, Sinner F, Birngruber T. Comparison of cerebral Open Flow Microperfusion and Microdialysis when sampling small lipophilic and small hydrophilic substances. J Neurosci Methods. 2019;311:394–401. doi:10.1016/j.jneumeth.2018.09.024.
   PubMed Web of Science ®Google Scholar
• Bien-Ly N, Yu YJ, Bumbaca D, Elstrott J, Boswell CA, Zhang Y, Luk W, Lu Y, Dennis MS, Weimer RM, et al. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. J Exp Med. 2014;211(2):233–44. doi:10.1084/jem.20131660.
   PubMed Web of Science ®Google Scholar
• Rosenbloom AJ, Sipe DM, Weedn VW. Microdialysis of proteins: performance of the CMA/20 probe. J Neurosci Methods. 2005;148(2):147–53. doi:10.1016/j.jneumeth.2005.04.018.
   PubMed Web of Science ®Google Scholar
• De Lange EC, Danhof M, De Boer AG, Breimer DD. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res Brain Res Rev. 1997;25(1):27–49. doi:10.1016/S0165-0173(97)00014-3.
   PubMedGoogle Scholar
• Mitala CM, Wang Y, Borland LM, Jung M, Shand S, Watkins S, Weber SG, Michael AC. Impact of microdialysis probes on vasculature and dopamine in the rat striatum: a combined fluorescence and voltammetric study. J Neurosci Methods. 2008;174(2):177–85. doi:10.1016/j.jneumeth.2008.06.034.
   PubMed Web of Science ®Google Scholar
• Birngruber T, Ghosh A, Hochmeister S, Asslaber M, Kroath T, Pieber TR, Sinner F. Long-term implanted cOFM probe causes minimal tissue reaction in the brain. PLoS One. 2014;9(3):e90221. doi:10.1371/journal.pone.0090221.
   PubMed Web of Science ®Google Scholar
• Kamath AV. Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies. Drug Discov Today Technol. 2016;21–22:75–83. doi:10.1016/j.ddtec.2016.09.004.
   PubMedGoogle Scholar
• Wolak DJ, Pizzo ME, Thorne RG. Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging. J Control Release. 2015;197:78–86. doi:10.1016/j.jconrel.2014.10.034.
   PubMed Web of Science ®Google Scholar
• Webster CI, Caram-Salas N, Haqqani AS, Thom G, Brown L, Rennie K, Yogi A, Costain W, Brunette E, Stanimirovic DB. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1. FASEB J. 1927–40;2016:5.
   Google Scholar
• Wang Q, Delva L, Weinreb PH, Pepinsky RB, Graham D, Veizaj E, Cheung AE, Chen W, Nestorov I, Rohde E, et al. Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration. Fluids Barriers CNS. 2018;15(1):10. doi:10.1186/s12987-018-0093-6.
   PubMedGoogle Scholar
• Tabernero A, Granda B, Medina A, Sánchez-Abarca LI, Lavado E, Medina JM. Albumin promotes neuronal survival by increasing the synthesis and release of glutamate. J Neurochem. 2002;81(4):881–91. doi:10.1046/j.1471-4159.2002.00843.x.
   PubMed Web of Science ®Google Scholar
• Vanni S, Zattoni M, Moda F, Giaccone G, Tagliavini F, Haïk S, Deslys JP, Zanusso G, Ironside JW, Carmona M, et al. Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases. Front Neurosci. 2018;12:8. doi:10.3389/fnins.2018.00008.
   PubMed Web of Science ®Google Scholar
• Müller M, Müller M. SpringerLink Microdialysis in Drug Development, 1st 2013. New York: Springer New York: Imprint: Springer; 2013.
   Google Scholar
• Thiollier T, Wu C, Porras G, Bezard E, Li Q, Zhang J, Contamin H. Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics. Animal Model Exp Med. 2018;1(4):314–21. doi:10.1002/ame2.12046.
   PubMedGoogle Scholar
• Myers RD, Adell A, Lankford MF. Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review. Neurosci Biobehav Rev. 1998;22(3):371–87. doi:10.1016/S0149-7634(97)00025-0.
   PubMed Web of Science ®Google Scholar
• Kottegoda S, Shaik I, Shippy SA. Demonstration of low flow push-pull perfusion. J Neurosci Methods. 2002;121(1):93–101. doi:10.1016/S0165-0270(02)00245-5.
   PubMed Web of Science ®Google Scholar
• Menacherry S, Hubert W, Justice JB. In vivo calibration of microdialysis probes for exogenous compounds. Anal Chem. 1992;64(6):577–83. doi:10.1021/ac00030a003.
   PubMed Web of Science ®Google Scholar
• Cremers TI, De Lange E C, De Vries MG, Ebert B, Huinink KD, Van Loon J. P, V D Hart M, Westerink B H. Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique. J Neurosci Methods. 2009;178:249–54.
   PubMed Web of Science ®Google Scholar
• Benveniste H. Brain microdialysis. J Neurochem. 1989;52(6): 1667–79.
   PubMed Web of Science ®Google Scholar
• Schaupp L, Ellmerer M, Brunner GA, Wutte A, Sendlhofer G, Trajanoski Z, Skrabal F, Pieber TR, Wach P. Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion. Am J Physiol. 1999;276(2):E401–8. doi:10.1152/ajpendo.1999.276.2.E401.
   PubMedGoogle Scholar
• Shackelford C, Long G, Wolf J, Okerberg C, Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol. 2002;30(1):93–96. doi:10.1080/01926230252824761.
   PubMed Web of Science ®Google Scholar
• Schafer KA, Eighmy J, Fikes JD, Halpern WG, Hukkanen RR, Long GG, Meseck EK, Patrick DJ, Thibodeau MS, Wood CE, et al. Use of Severity Grades to Characterize Histopathologic Changes. Toxicol Pathol. 2018;46(3):256–65. doi:10.1177/0192623318761348.
   PubMed Web of Science ®Google Scholar